55 related articles for article (PubMed ID: 12649342)
1. Molecular diagnosis of oligodendroglioma in paraffin sections.
Hatanpaa KJ; Burger PC; Eshleman JR; Murphy KM; Berg KD
Lab Invest; 2003 Mar; 83(3):419-28. PubMed ID: 12649342
[TBL] [Abstract][Full Text] [Related]
2. A Targeted Next-Generation Sequencing Panel to Genotype Gliomas.
Guarnaccia M; Guarnaccia L; La Cognata V; Navone SE; Campanella R; Ampollini A; Locatelli M; Miozzo M; Marfia G; Cavallaro S
Life (Basel); 2022 Jun; 12(7):. PubMed ID: 35888045
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
McAleenan A; Jones HE; Kernohan A; Robinson T; Schmidt L; Dawson S; Kelly C; Spencer Leal E; Faulkner CL; Palmer A; Wragg C; Jefferies S; Brandner S; Vale L; Higgins JP; Kurian KM
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013387. PubMed ID: 35233774
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic review.
Brandner S; McAleenan A; Jones HE; Kernohan A; Robinson T; Schmidt L; Dawson S; Kelly C; Leal ES; Faulkner CL; Palmer A; Wragg C; Jefferies S; Vale L; Higgins JPT; Kurian KM
Neuropathol Appl Neurobiol; 2022 Jun; 48(4):e12790. PubMed ID: 34958131
[TBL] [Abstract][Full Text] [Related]
5. Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomas.
Ball MK; Kollmeyer TM; Praska CE; McKenna ML; Giannini C; Raghunathan A; Jentoft ME; Lachance DH; Kipp BR; Jenkins RB; Ida CM
Neurooncol Adv; 2020; 2(1):vdaa109. PubMed ID: 33205043
[TBL] [Abstract][Full Text] [Related]
6. Three-Dimensional Nuclear Telomere Profiling as a Biomarker for Recurrence in Oligodendrogliomas: A Pilot Study.
Gadji M; Mathur S; Bélanger B; Jangamreddy JR; Lamoureux J; Tsanaclis AMC; Fortin D; Drouin R; Mai S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198352
[TBL] [Abstract][Full Text] [Related]
7. Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomas.
Oughourlian TC; Yao J; Hagiwara A; Nathanson DA; Raymond C; Pope WB; Salamon N; Lai A; Ji M; Nghiemphu PL; Liau LM; Cloughesy TF; Ellingson BM
Neuroradiology; 2021 Jun; 63(6):857-868. PubMed ID: 33106922
[TBL] [Abstract][Full Text] [Related]
8. Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI.
Yao J; Chakhoyan A; Nathanson DA; Yong WH; Salamon N; Raymond C; Mareninov S; Lai A; Nghiemphu PL; Prins RM; Pope WB; Everson RG; Liau LM; Cloughesy TF; Ellingson BM
Neuro Oncol; 2019 Sep; 21(9):1184-1196. PubMed ID: 31066901
[TBL] [Abstract][Full Text] [Related]
9. The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma.
Diplas BH; He X; Brosnan-Cashman JA; Liu H; Chen LH; Wang Z; Moure CJ; Killela PJ; Loriaux DB; Lipp ES; Greer PK; Yang R; Rizzo AJ; Rodriguez FJ; Friedman AH; Friedman HS; Wang S; He Y; McLendon RE; Bigner DD; Jiao Y; Waitkus MS; Meeker AK; Yan H
Nat Commun; 2018 May; 9(1):2087. PubMed ID: 29802247
[TBL] [Abstract][Full Text] [Related]
10. IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation.
Oktay Y; Ülgen E; Can Ö; Akyerli CB; Yüksel Ş; Erdemgil Y; Durası IM; Henegariu OI; Nanni EP; Selevsek N; Grossmann J; Erson-Omay EZ; Bai H; Gupta M; Lee W; Turcan Ş; Özpınar A; Huse JT; Sav MA; Flanagan A; Günel M; Sezerman OU; Yakıcıer MC; Pamir MN; Özduman K
Sci Rep; 2016 Jun; 6():27569. PubMed ID: 27282637
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnostics: techniques and recommendations for 1p/19q assessment.
Woehrer A; Hainfellner JA
CNS Oncol; 2015; 4(5):295-306. PubMed ID: 26545171
[TBL] [Abstract][Full Text] [Related]
12. Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1.
Cahill DP; Louis DN; Cairncross JG
CNS Oncol; 2015; 4(5):287-94. PubMed ID: 26545048
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients.
Rodriguez FJ; Tihan T; Lin D; McDonald W; Nigro J; Feuerstein B; Jackson S; Cohen K; Burger PC
Am J Surg Pathol; 2014 Aug; 38(8):1058-70. PubMed ID: 24805856
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA profiles reveal three molecular subtypes in glioma.
Li R; Qian J; Wang YY; Zhang JX; You YP
CNS Neurosci Ther; 2014 Apr; 20(4):339-43. PubMed ID: 24393335
[TBL] [Abstract][Full Text] [Related]
15. LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma.
Yeung JT; Hamilton RL; Ohnishi K; Ikeura M; Potter DM; Nikiforova MN; Ferrone S; Jakacki RI; Pollack IF; Okada H
Clin Cancer Res; 2013 Apr; 19(7):1816-26. PubMed ID: 23401227
[TBL] [Abstract][Full Text] [Related]
16. Differentiation between oligodendroglioma genotypes using dynamic susceptibility contrast perfusion-weighted imaging and proton MR spectroscopy.
Chawla S; Krejza J; Vossough A; Zhang Y; Kapoor GS; Wang S; O'Rourke DM; Melhem ER; Poptani H
AJNR Am J Neuroradiol; 2013 Aug; 34(8):1542-9. PubMed ID: 23370479
[TBL] [Abstract][Full Text] [Related]
17. Chromogenic in situ hybridization is a reliable alternative to fluorescence in situ hybridization for diagnostic testing of 1p and 19q loss in paraffin-embedded gliomas.
Lass U; Hartmann C; Capper D; Herold-Mende C; von Deimling A; Meiboom M; Mueller W
Brain Pathol; 2013 May; 23(3):311-8. PubMed ID: 23107103
[TBL] [Abstract][Full Text] [Related]
18. Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies.
Masui K; Cloughesy TF; Mischel PS
Neuropathol Appl Neurobiol; 2012 Jun; 38(3):271-91. PubMed ID: 22098029
[TBL] [Abstract][Full Text] [Related]
19. Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: superior results compared with microsatellite analysis.
Harada S; Henderson LB; Eshleman JR; Gocke CD; Burger P; Griffin CA; Batista DA
J Mol Diagn; 2011 Sep; 13(5):541-8. PubMed ID: 21726663
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma multiforme in the Muir-Torre syndrome.
Binder ZA; Johnson MW; Joshi A; Hann CL; Griffin CA; Olivi A; Riggins GJ; Gallia GL
Clin Neurol Neurosurg; 2011 Jun; 113(5):411-5. PubMed ID: 21288634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
